Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Matthew Scott Ernst, Vishal Navani, J. Connor Wells, Ziad Bakouny, Frede Donskov, Naveen S. Basappa, Lori Wood, Luís Meza, Sumanta K. Pal, Bernadett Szabados, Thomas Powles, Benoit Beuselinck, Rana R. McKay, Jae‐Lyun Lee, D. Scott Ernst, Anil Kapoor, Takeshi Yuasa, Toni K. Choueiri, Daniel Y.C. Heng
Topics & Concepts
MedicineRenal cell carcinomaSubgroup analysisSystemic therapyInternal medicineNephrectomyOncologyProportional hazards modelImmunotherapyUrologyCancerSurgeryKidneyBreast cancerConfidence intervalRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers